biotech
Rotarix Rotavirus Vaccine Approved In The EU
Filed in archive Corporate and Industrial News , Drugs, Vaccines and Therapeutics , Patents and Intellectual Property Rights by ruth on March 1, 2006
Rotavirus: Methods & Protocols (Methods in Molecular Medicine)

The European Commission has granted approval for GlaxoSmithKline's Rotarix, making it the first rotavirus vaccine available to children in Europe for the prevention of gastroenteritis caused by rotavirus.

"European approval marks a significant milestone for the global commercialization of Rotarix(R), which has already been approved for commercial use in an additional 33 countries. It brings in a milestone payment from GSK and leads to a substantial payment of $40 million to Avant through its transaction with Paul Royalty Fund ("PRF")." In May 2005, AVANT entered into an agreement whereby an affiliate of PRF purchased an interest in the net royalties AVANT will receive on worldwide sales of Rotarix(R).


For more details of the agreement with PRF, refer to Avant Immunotherapeutics' press release.

Permalink: Rotarix Rotavirus Vaccine Approved In The EU
Tags: rotavirus  gastroenteritis  biotech  vaccine  rotarix  rotavirus+vaccine  rotarix+rotavirus  vaccine+approv 
Trackback: http://publish.creative-weblogging.com/publish/mt-tb.pl/16487
img Addthis img Ask img Blinklist img del.icio.us img Digg img Fark img Facebook img Google img Lycos img Ma.gnolia Add this page to Mister Wong Mr Wong img Netscape img Netvousz img Newsvine img Reddit img StumbleUpon img Slashdot img Tailrank img Technorati img Wink img Yahoo

Vote for Rotarix Rotavirus Vaccine Approved In The EU:

  • Currently 9.50/10
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
Rating: 9.50 out of 4 vote(s) cast.
Subscribe
Share It
Popular posts from our other blogs:
RSSrss
See all blog subscribe options
Google google
What is RSS?
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
Newsletter

TwitterFollow us on Twitter!